- ICH GCP
- Register voor klinische proeven in de VS.
- Klinische proef NCT00636779
BraveNet Integrative Medicine Descriptive Study (BraveNet)
BraveNet Multi-Center Integrative Medicine Survey
Studie Overzicht
Toestand
Conditie
Gedetailleerde beschrijving
Specific Aims of BraveNet:
- Demonstrate feasibility for the nine sites of BraveNet to coordinate in specifying data elements, developing and implementing smooth data collection procedures, analyzing the data, publishing and disseminating the results through scientific conferences and journals.
Describe the patients seeking care at Integrative Medicine centers, in terms of:
- demographics, presenting symptoms, health conditions, type of care sought, and expectations for treatment;
- quality of life, mood, stress; and
- lifestyle factors.
- Explore potential patterns within the sample [e.g., do the survey scores vary by demographics, by condition, by type patient (new vs return), by type of help sought, etc.].
- Utilize above data as pilot data for future studies and funding opportunities.
Up to five hundred eligible patients seen at each of the nine participating Centers will be approached (by mail, phone, at the time of their visit, etc.) and invited to consent to the paper and pencil study. The patient survey will clearly state that participation is voluntary with a written consent to participate on the front. Individual practices will report the response rate in order to monitor the potential effect of volunteer bias. Participant completion of questionnaires should take 15 to 30 minutes, and should be completed within 2 weeks of the patient visit., The corresponding provider form will be completed by the provider/research staff within 5 days of the visit.
Measures:
- Baseline Questionnaires - Demographics and reason for visit
- Quality of Life. The SF-12 (Short Form 12)
- Mood (Depression). The Center for Epidemiologic Studies Depression Scale (CES-D)
- Stress. The Perceived Stress Scale (PSS)
- Visual Analog Scales (VAS). Four self-report VASs will be used to measure aspects of pain, fatigue and restfulness of sleep.
- Provider Form. Providers/ Research Staff will complete this form to indicate the type of provider seen, the CPT codes used to describe/bill for the service, the services provided, and the provider's assessment of current medical conditions/co-morbidities.
Studietype
Inschrijving (Werkelijk)
Contacten en locaties
Studie Locaties
-
-
California
-
La Jolla, California, Verenigde Staten, 92037
- Scripps Center for Integrative Medicine
-
San Francisco, California, Verenigde Staten, 94143
- Osher Center for Integrative Medicine
-
Santa Monica, California, Verenigde Staten, 90405
- Venice Family Clinic
-
-
Maryland
-
Baltimore, Maryland, Verenigde Staten, 21207
- University of Maryland Center for Integrative Medicine
-
-
Minnesota
-
Minneapolis, Minnesota, Verenigde Staten, 55407
- Penny George Institute for Health and Healing
-
-
North Carolina
-
Durham, North Carolina, Verenigde Staten, 27710
- Duke Integrative Medicine
-
-
Ohio
-
Cincinnati, Ohio, Verenigde Staten, 45236
- Alliance Center for Integrative Medicine
-
-
Pennsylvania
-
Philadelphia, Pennsylvania, Verenigde Staten, 19107
- Jefferson-Myrna Brind Center of Integrative Medicine
-
-
Deelname Criteria
Geschiktheidscriteria
Leeftijden die in aanmerking komen voor studie
Accepteert gezonde vrijwilligers
Geslachten die in aanmerking komen voor studie
Bemonsteringsmethode
Studie Bevolking
Beschrijving
Inclusion Criteria:
Subjects will be eligible for inclusion in this study only if all of the following criteria apply:
- Age: At least 18 years of age.
- Patient Status: Participants are eligible if seen individually by any type of clinician on the day of the visit.
- English or Spanish Literacy: Ability to read and write English or Spanish as confirmed by the site personnel and ability to provide informed consent.
Exclusion Criteria:
Subjects will be excluded from this study if any of the following criteria apply:
- Cognitive Impairment: A subject will not be eligible if he/she has a history of psychiatric disease, dementia, Alzheimer's disease, or other conditions which will limit the validity of providing informed consent to participate in the study.
- Inability to read and write in English or Spanish.
- Participating only in educational Center activities, not as a clinical patient.
Studie plan
Hoe is de studie opgezet?
Ontwerpdetails
- Observatiemodellen: Cohort
- Tijdsperspectieven: Dwarsdoorsnede
Cohorten en interventies
Groep / Cohort |
|---|
|
1
Up to five hundred eligible patients seen at each of the nine participating Integrative Medicine Centers will be approached (by mail, phone, at the time of their visit, etc.) and invited to consent to the paper and pencil study.
|
Wat meet het onderzoek?
Primaire uitkomstmaten
Uitkomstmaat |
Tijdsspanne |
|---|---|
|
Describe the patients seeking care at Integrative Medicine centers, in terms of:a.demographics, presenting symptoms, health conditions, type of care sought, and expectations for treatment; b.quality of life, mood, stress; and c.lifestyle factors.
Tijdsspanne: Once per patient
|
Once per patient
|
Secundaire uitkomstmaten
Uitkomstmaat |
Tijdsspanne |
|---|---|
|
Explore potential patterns within the sample [e.g., do the survey scores vary by demographics, by condition, by type patient (new vs return), by type of help sought, etc.]and utilize data as pilot data for future studies and funding opportunities.
Tijdsspanne: Once all surveys have been entered into the EDC system
|
Once all surveys have been entered into the EDC system
|
Medewerkers en onderzoekers
Sponsor
Medewerkers
Onderzoekers
- Hoofdonderzoeker: Rowena Dolor, MD, Duke Clinical Research Institute
- Hoofdonderzoeker: Ruth Wolever, PhD, Duke Integrative Medicine Center
Studie record data
Bestudeer belangrijke data
Studie start
Primaire voltooiing (Werkelijk)
Studie voltooiing (Werkelijk)
Studieregistratiedata
Eerst ingediend
Eerst ingediend dat voldeed aan de QC-criteria
Eerst geplaatst (Schatting)
Updates van studierecords
Laatste update geplaatst (Schatting)
Laatste update ingediend die voldeed aan QC-criteria
Laatst geverifieerd
Meer informatie
Termen gerelateerd aan deze studie
Andere studie-ID-nummers
- Pro00006850
Informatie over medicijnen en apparaten, studiedocumenten
Bestudeert een door de Amerikaanse FDA gereguleerd geneesmiddel
Bestudeert een door de Amerikaanse FDA gereguleerd apparaatproduct
product vervaardigd in en geëxporteerd uit de V.S.
Deze informatie is zonder wijzigingen rechtstreeks van de website clinicaltrials.gov gehaald. Als u verzoeken heeft om uw onderzoeksgegevens te wijzigen, te verwijderen of bij te werken, neem dan contact op met register@clinicaltrials.gov. Zodra er een wijziging wordt doorgevoerd op clinicaltrials.gov, wordt deze ook automatisch bijgewerkt op onze website .